Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2012
03/22/2012WO2012037530A1 Stabilization of immunoglobulins and other proteins through aqueous formulations with sodium chloride at weak acidic to neutral ph
03/22/2012WO2012037485A2 Methods of inhibiting alphavirus replication and treating alphavirus infection
03/22/2012WO2012037093A1 Compositions for treating cancer treatment - related fatigue
03/22/2012WO2012037078A2 Immunogenic respiratory syncytial virus glycoprotein-containing vlps and related compositions, constructs, and therapeutic methods
03/22/2012WO2012037004A1 Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
03/22/2012WO2012036392A2 Human anti-epidermal growth factor receptor fab antibody and a pharmaceutical composition for treating tumours comprising the same
03/22/2012WO2012036391A2 Surface expression vector of porcine circovirus type 2 (pcv2) gene and salmonella vaccine strain transformed with same
03/22/2012WO2012035558A2 A synthetic immunogen useful for generating long lasting immunity and protection against pathogens
03/22/2012WO2012035519A1 Immunogenic compositions
03/22/2012WO2012035518A1 Compositions and methods for treatment of drug resistant multiple myeloma
03/22/2012WO2012035330A2 Vaccines
03/22/2012WO2012034203A1 Attenuated strain of corynebacterium pseudotuberculosis and live vaccine against caseous lymphadenite
03/22/2012WO2012034197A1 Synthetic gene for expressing sm-14 in pichia pastoris, methods for producing and purifying sm-14 and the use thereof as a vaccine and diagnostic medium
03/22/2012WO2012015758A3 Methods of treating pain
03/22/2012WO2012006341A3 Anti-ron antibodies
03/22/2012WO2012003234A3 Env trimer immunogens
03/22/2012WO2011163593A3 Induction of immune response
03/22/2012WO2011161551A3 Omv (outer membrane vesicle) vaccines
03/22/2012WO2011139846A3 Compositions and methods for reduced scarring and for treatment of fibrosis
03/22/2012WO2011133925A3 Targeted and light-activated cytosolic drug delivery
03/22/2012WO2011085158A3 Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies
03/22/2012WO2010112458A8 Composition and methods of use for therapeutic antibodies specific for the il-12 receptore betal subunit
03/22/2012WO2008052173A9 Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
03/22/2012WO2005032457A3 Vectors and methods for immunization against norwalk virus using transgenic plants
03/22/2012US20120071704 Mitochondrial localization of muc1
03/22/2012US20120071630 Nucleic Acid and Amino Acid Sequences of Infectious Salmon Anaemia Virus and Their Use as Vaccines
03/22/2012US20120071545 Compositions and methods for treatment of bacterial and mycobacterial infections
03/22/2012US20120071443 Nanoparticles
03/22/2012US20120070500 Nanoparticles Of Cerium Oxide Targeted To An Amyloid-Beta Antigen Of Alzheimer's Disease And Associated Methods
03/22/2012US20120070493 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/22/2012US20120070491 Casb7439 constructs
03/22/2012US20120070488 Method of inducing neutralizing antibodies to human immunodeficiency virus
03/22/2012US20120070467 Ophthalmic Drug Delivery
03/22/2012US20120070464 Monoparamunity inducers based on attenuated rabbit myxomaviruses
03/22/2012US20120070462 Targeted Gene Delivery to Dendritic Cells
03/22/2012US20120070461 Use of myeloid cell biomarkers for the diagnosis of cancer
03/22/2012US20120070460 Dendritic cell modulatory molecule
03/22/2012US20120070459 Method for keeping a foot-and-mouth disease vaccine available for emergency vaccination
03/22/2012US20120070458 Adjuvanting meningococcal factor h binding protein
03/22/2012US20120070457 Polypeptides from neisseria meningitidis
03/22/2012US20120070456 Polypeptide carrier protein
03/22/2012US20120070455 Influenza vaccine
03/22/2012US20120070454 Dengue vaccine, pharmaceutical composition comprising the same, nucleotide sequence and antibody composition
03/22/2012US20120070453 Methods for Preparing and Delivering Adjuvant Compositions
03/22/2012US20120070452 Immunoadjuvant composition and use thereof
03/22/2012US20120070450 Leukemia stem cell markers
03/22/2012US20120070449 Methods of treating inflammation
03/22/2012US20120070448 Anti-il-3ra antibody for use in treatment of blood tumor
03/22/2012US20120070447 Methods of administering / dosing anti-rsv antibodies for prophylaxis and treatment
03/22/2012US20120070446 Rsv specific binding molecule
03/22/2012US20120070445 Brain-derived gonadotropins and cognition
03/22/2012US20120070443 Pde1 as a target therapeutic in heart disease
03/22/2012US20120070442 Methods and compositions for treating cancer
03/22/2012US20120070441 Extracellular yaluronidase from streptomyces koganeiensis
03/22/2012US20120070440 Therapeutic use of anti-cs1 antibodies
03/22/2012US20120070439 Antigen-binding proteins
03/22/2012US20120070438 Methods for Treating Melanoma
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/22/2012US20120070436 Antigen-binding proteins
03/22/2012US20120070435 Chimeric antigens for eliciting an immune response
03/22/2012US20120070434 Antibodies containing therapeutic tpo/epo mimetic peptides
03/22/2012US20120070433 Flavonoid hydrogel
03/22/2012US20120070432 Treatment of pancreatic cancer using a dr5 agonist in combination with gemcitabine
03/22/2012US20120070431 Methods for treating chronic obstructive pulmonary disease
03/22/2012US20120070430 Identification of tumor-associated markers for diagnosis and therapy
03/22/2012US20120070429 Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof
03/22/2012US20120070428 Treatment of vascularized pigment epithelial detachment with anti-vegf therapy
03/22/2012US20120070427 Vortex-induced silk fibroin gelation for encapsulation and delivery
03/22/2012US20120070426 Peptide-based passive immunization therapy for the treatment of atherosclerosis
03/22/2012US20120070415 Azido nucleosides and nucleotide analogs
03/22/2012US20120070412 HCV Inhibitor and Therapeutic Agent Combinations
03/22/2012US20120070408 Methods and compositions for treating lupus
03/22/2012US20120070406 Therapeutic protein compositions having reduced immunogenicity and/or improved efficacy
03/22/2012US20120070404 Increasing cancer patient survival time by administration of dithio-containing compounds
03/22/2012US20120070379 Immunotherapy regimes dependent on apoe status
03/22/2012US20120070370 Spiro 1,3,4-thiadiazoline derivatives as ksp inhibitors
03/22/2012US20120070369 Hif inhibitors and use thereof
03/22/2012US20120070368 Methods of Using C-Met Modulators
03/22/2012CA2811305A1 Immunogenic compositions
03/22/2012CA2811208A1 Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
03/22/2012CA2810734A1 Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph
03/22/2012CA2810731A1 Stabilization of immunoglobulins and other proteins through aqueous formulation with sodium chloride at weak acidic to neutral ph
03/21/2012EP2431478A1 Methods and compositions for expressing negative-sense viral RNA in canine cells
03/21/2012EP2431468A1 Interleukin-1 conjugates and uses thereof
03/21/2012EP2431463A1 Test agent for visceral obesity and use thereof
03/21/2012EP2431393A1 Anti-axl antibody
03/21/2012EP2431384A1 Method and device for extracting cedar pollen proteins
03/21/2012EP2431382A1 Yersinia SPP, polypeptides and methods of use
03/21/2012EP2431381A2 Synthetic oligopeptides designed from mite cysteine proteases and methods for the production of igy polyclonal antibodies for the detection of intradomiciliary mites
03/21/2012EP2431053A1 Novel glycosylated peptide target in neoplastic cells
03/21/2012EP2431052A1 Protein for the immunocastration for mammals
03/21/2012EP2431050A1 Methods of treating cancer using IL-21 and monoclonal antibody therapy
03/21/2012EP2430157A1 Antigen peptide and use thereof
03/21/2012EP2430153A1 Methods of using immunoglobulin aggregates
03/21/2012EP2430151A2 Menigococcus vaccine containing lipooligosaccharide (los) from modified strains of l6 immunotype neisseria meningitidis
03/21/2012EP2430051A1 Compositions containing antibodies for treating cd5+ hla-dr+ b or t cell related diseases
03/21/2012EP2430050A1 Humanized axl antibodies
03/21/2012EP2430049A1 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
03/21/2012EP2430046A1 Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
03/21/2012EP2430033A1 Chemically programmable immunity
1 ... 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 ... 1823